Yohan Suryo Rahmanto

ORCID

Publication Activity (10 Years)

Years Active: 2018-2020
Publications (10 Years): 6

Top Venues

Oncogene

Cancers

Cancer research

The Journal of pathology

Johns Hopkins School of Medicine

University of Sydney (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Johns Hopkins School of Medicine

United States

Post-Doc :: Pathology

University of Sydney

Australia

Research Fellow :: Pathology

Education History

University of Sydney

Australia

PHD :: Pathology

University of New South Wales

Australia

BSC :: Biotechnology

Publications

Yao-An Shen, Jiaxin Hong, Ryoichi Asaka, Fang-Chi Hsu, Yohan Suryo Rahmanto, Jin-Gyoung Jung, Yu-Wei Chen, Ting-Tai Yen, Alicja Tomaszewski, Cissy Zhang, Nabeel Attarwala, Angelo M DeMarzo, Ben Davidson, Chi-Mu Chuang, Xi Chen, Stephanie Gaillard, Anne Le, Ie-Ming Shih, Tian-Li Wang
Inhibition of the MYC-Regulated Glutaminase Metabolic Axis Is an Effective Synthetic Lethal Approach for Treating Chemoresistant Ovarian Cancers. Cancer research 80 (20) (2020)
Yohan Suryo Rahmanto, Wenjing Shen, Xu Shi, Xi Chen, Yu Yu, Zheng-Cheng Yu, Tsutomu Miyamoto, Meng-Horng Lee, Vivek Singh, Ryoichi Asaka, Geoffrey Shimberg, Michele I Vitolo, Stuart S Martin, Denis Wirtz, Ronny Drapkin, Jianhua Xuan, Tian-Li Wang, Ie-Ming Shih
Inactivation of Arid1a in the endometrium is associated with endometrioid tumorigenesis through transcriptional reprogramming. Nature communications 11 (1) (2020)
Youngran Park, Michael Herman Chui, Yohan Suryo Rahmanto, Zheng-Cheng Yu, Raghavendra A Shamanna, Marina A Bellani, Stephanie Gaillard, Ayse Ayhan, Akila Viswanathan, Michael M Seidman, Sonia Franco, Anthony K L Leung, Vilhelm A Bohr, Ie-Ming Shih, Tian-Li Wang
Loss of ARID1A in Tumor Cells Renders Selective Vulnerability to Combined Ionizing Radiation and PARP Inhibitor Therapy. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (18) (2019)
Lin-Yu Chen, Rui-Lan Huang, Michael Wy Chan, Pearlly S Yan, Tien-Shuo Huang, Ren-Chin Wu, Yohan Suryo Rahmanto, Po-Hsuan Su, Yu-Chun Weng, Jian-Liang Chou, Tai-Kuang Chao, Yu-Chi Wang, Ie-Ming Shih, Hung-Cheng Lai
TET1 reprograms the epithelial ovarian cancer epigenome and reveals casein kinase 2α as a therapeutic target. The Journal of pathology 248 (3) (2019)
Mudra Binju, Monica Angelica Amaya-Padilla, Graeme Wan, Hendra Gunosewoyo, Yohan Suryo Rahmanto, Yu Yu
Therapeutic Inducers of Apoptosis in Ovarian Cancer. Cancers 11 (11) (2019)
Yu Yu, Yohan Suryo Rahmanto, Meng-Horng Lee, Pei-Hsun Wu, Jude M Phillip, Chuan-Hsiang Huang, Michele I Vitolo, Stephanie Gaillard, Stuart S Martin, Denis Wirtz, Ie-Ming Shih, Tian-Li Wang
Inhibition of ovarian tumor cell invasiveness by targeting SYK in the tyrosine kinase signaling pathway. Oncogene 37 (28) (2018)

Yohan Suryo Rahmanto.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Yohan Suryo Rahmanto